Keywords
Last Name
Institution

Lisa M Holle PharmD, BCOP

TitleAssistant Clinical Professor
InstitutionUniversity of Connecticut
DepartmentPharmacy Practice
AddressUNIT 3092
Pharmacy/Bio, UNIT 3092
69 N Eagleville Road
Phone860-679-5195
Fax860-486-4733
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jensen CM, Holle LM. Ledipasvir-Sofosbuvir: A Once-Daily Oral Treatment Option for Chronic Hepatitis C Virus Genotype 1 Infection. Pharmacotherapy. 2016 May; 36(5):562-74. PMID: 27027412.
      View in: PubMed
    2. Holle LM, Puri S, Clement JM. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice. J Oncol Pharm Pract. 2016 Jun; 22(3):511-6. PMID: 25900102.
      View in: PubMed
    3. Pherwani N, Ghayad JM, Holle LM, Karpiuk EL. Outpatient management of febrile neutropenia associated with cancer chemotherapy: risk stratification and treatment review. Am J Health Syst Pharm. 2015 Apr 15; 72(8):619-31. PMID: 25825185.
      View in: PubMed
    4. Khurana A, Mitsis D, Kowlgi GN, Holle LM, Clement JM. Atypical presentation of fever as hypersensitivity reaction to oxaliplatin. J Oncol Pharm Pract. 2016 Apr; 22(2):319-24. PMID: 25361599.
      View in: PubMed
    5. Dadla A, Tannenbaum S, Yates B, Holle L. Delayed hypersensitivity reaction related to the use of pegfilgrastim. J Oncol Pharm Pract. 2015 Dec; 21(6):474-7. PMID: 24993705.
      View in: PubMed
    6. Holle LM, Boehnke Michaud L. Oncology pharmacists in health care delivery: vital members of the cancer care team. J Oncol Pract. 2014 May; 10(3):e142-5. PMID: 24618076.
      View in: PubMed
    7. Bois E, Holle LM, Farooq U. Late onset imatinib-induced Stevens-Johnson syndrome. J Oncol Pharm Pract. 2014 Dec; 20(6):476-8. PMID: 24399835.
      View in: PubMed
    8. Cavanagh TT, Holle LM. Potential new gene therapy option with sitimagene ceradenovec for newly diagnosed patients with glioblastoma multiforme. Cancer Biol Ther. 2014 Mar 1; 15(3):263-5. PMID: 24352098; PMCID: PMC3974826.
    9. McBride A, Holle LM, Westendorf C, Sidebottom M, Griffith N, Muller RJ, Hoffman JM. National survey on the effect of oncology drug shortages on cancer care. Am J Health Syst Pharm. 2013 Apr 1; 70(7):609-17. PMID: 23515514.
      View in: PubMed
    10. Walsh T, Morris AK, Holle LM, Callander N, Bradshaw P, Valley AW, Clark G, Freytes CO. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial. Bone Marrow Transplant. 2004 Dec; 34(11):963-8. PMID: 15489869.
      View in: PubMed
    11. Jung L, Holle L, Dalton WS. Discovery, Development, and clinical applications of bortezomib. Oncology (Williston Park). 2004 Dec; 18(14 Suppl 11):4-13. PMID: 15688597.
      View in: PubMed
    12. Gazitt Y, Freytes CO, Callander N, Tsai TW, Alsina M, Anderson J, Holle L, Cruz J, Devore P, McGrath M, West G, Alvarez R, Montgomery W. Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization. J Hematother. 1999 Apr; 8(2):173-83. PMID: 10349911.
      View in: PubMed
    13. Holle LM. Pegaspargase: an alternative? Ann Pharmacother. 1997 May; 31(5):616-24. PMID: 9161659.
      View in: PubMed
    14. Holle LM, Gidal BE, Collins DM. Valproate in status epilepticus. Ann Pharmacother. 1995 Oct; 29(10):1042-4. PMID: 8845544.
      View in: PubMed
    Holle's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _